A Subset of the Follicular Variant of Papillary Thyroid Carcinoma Harbors the PAX8-PPARγ Translocation

The occurrence of the PAX8-PPARγ fusion gene is thought to be restricted to follicular tumors (adenomas and carcinomas) of the thyroid (FTA and FTC). Using interphase fluorescent in situ hybridization (FISH), together with recombinant tissue-type polymerase chain reaction (RT-PCR) and immunohistochemistry, we detected the PAX8-PPARγ translocation in 4 of 8 cases of the follicular variant of papillary thyroid carcinoma (FVPTC) exclusively or almost exclusively (>95%) composed of follicles. The 4 tumors with the translocation were larger and apparently more invasive than the remaining tumors, but the series is too small to allow a statistically meaningful comparison of the data. Our findings show that follicular thyroid carcinoma (PTC) may also harbor the PAX8-PPARγ fusion gene and indicate that a subset of FVPTC shares some molecular features of FTA and FTC.

[1]  M. Santoro,et al.  BRAF mutations are not a major event in post-Chernobyl childhood thyroid carcinomas. , 2004, The Journal of clinical endocrinology and metabolism.

[2]  J. Shah,et al.  Follicular variant of papillary thyroid carcinoma: Genome‐wide appraisal of a controversial entity , 2004, Genes, chromosomes & cancer.

[3]  L. Sobrinho,et al.  Underexpression of peroxisome proliferator-activated receptor (PPAR)γ in PAX8/PPARγ-negative thyroid tumours , 2004, British Journal of Cancer.

[4]  V. Trovisco,et al.  BRAF mutations are associated with some histological types of papillary thyroid carcinoma , 2004, The Journal of pathology.

[5]  V. Trovisco,et al.  BRAF mutations and RET/PTC rearrangements are alternative events in the etiopathogenesis of PTC , 2003, Oncogene.

[6]  A. Fischer,et al.  Molecular profile and clinical-pathologic features of the follicular variant of papillary thyroid carcinoma. An unusually high prevalence of ras mutations. , 2003, American journal of clinical pathology.

[7]  Yuri E Nikiforov,et al.  RAS point mutations and PAX8-PPAR gamma rearrangement in thyroid tumors: evidence for distinct molecular pathways in thyroid follicular carcinoma. , 2003, The Journal of clinical endocrinology and metabolism.

[8]  A. Gill,et al.  Detection of the PAX8-PPARγ Fusion Oncogene in Both Follicular Thyroid Carcinomas and Adenomas , 2003 .

[9]  A. Gill,et al.  Detection of the PAX8-PPAR gamma fusion oncogene in both follicular thyroid carcinomas and adenomas. , 2003, The Journal of clinical endocrinology and metabolism.

[10]  L. Sobrinho,et al.  Expression of PAX8-PPARγ1 Rearrangements in Both Follicular Thyroid Carcinomas and Adenomas , 2002 .

[11]  M. Nikiforova,et al.  PAX8-PPAR&ggr; Rearrangement in Thyroid Tumors: RT-PCR and Immunohistochemical Analyses , 2002, The American journal of surgical pathology.

[12]  L. Sobrinho,et al.  Expression of PAX8-PPAR gamma 1 rearrangements in both follicular thyroid carcinomas and adenomas. , 2002, The Journal of clinical endocrinology and metabolism.

[13]  J. Soares,et al.  Karyotypic characterization of papillary thyroid carcinomas , 2001, Cancer.

[14]  C. J. Chen,et al.  PAX8-PPARgamma1 fusion oncogene in human thyroid carcinoma [corrected]. , 2000, Science.